VIOL Medical Launches V.CODE Symposium Series, Opening with Sylfirm X and the Clinical Logic of Precision RF
On May 14, VIOL Medical hosted the inaugural session of "V.CODE: SYLFIRM X" at the 3F Boardroom of Park Hyatt Seoul—a gathering where Sylfirm X heavy users came together to refine the clinical framework of dual-wave RF. V.CODE is the first domestic academic platform the company has launched since completing a phase of corporate redefinition (a 2025 controlling-stake acquisition by VIG Partners, a relocation to Pangyo, and a February 2026 rebrand), and it placed one message at its core: precise control of tissue response, not raw output. In a panel chaired by Dr. Jongwook Hong (Mulbangul Plastic Surgery Clinic), with Dr. Jaesung Park (Yonsei My View Clinic), Dr. Arim Min (Min & Min Clinic), and Dr. Hyunkyung Kim (Mouda Clinic), physicians shared frontline clinical know-how across a wide range: the 'delayed erythema' endpoint as a critical signal in refractory melasma, preliminary in-clinic scalp data showing an approximately 5% increase in hair count, the growing role of hADM-based ECM boosters such as Elravie Re2O and Juveàcell in skin booster combinations, and expanded indications including early-stage striae. How the V.CODE series—continuing with DUOTITE and Cellinew—extends as a new academic hub for K-EBD will be worth following.
#MedicalAestheticNews #VIOLMedical #SylfirmX #DrJongwookHong #MulbangulPlasticSurgery #DrJaesungPark #YonseiMyViewClinic #DrArimMin #MinandMinClinic #DrHyunkyungKim #MoudaClinic
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20058



Comments
Post a Comment